Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 22;77(8):1871-80.
doi: 10.1021/np5003548. Epub 2014 Aug 4.

Trichormamides A and B with Antiproliferative Activity from the Cultured Freshwater Cyanobacterium Trichormus sp. UIC 10339

Affiliations

Trichormamides A and B with Antiproliferative Activity from the Cultured Freshwater Cyanobacterium Trichormus sp. UIC 10339

Shangwen Luo et al. J Nat Prod. .

Abstract

Two new cyclic lipopeptides, trichormamides A (1) and B (2), were isolated from the cultured freshwater cyanobacterium Trichormus sp. UIC 10339. The strain was obtained from a sample collected in Raven Lake in Northern Wisconsin. The planar structures of trichormamides A (1) and B (2) were determined using a combination of spectroscopic analyses including HRESIMS and 1D and 2D NMR experiments. The absolute configurations of the amino acid residues were assigned by the advanced Marfey's method after acid hydrolysis. Trichormamide A (1) is a cyclic undecapeptide containing two D-amino acid residues (D-Tyr and D-Leu) and one β-amino acid residue (β-aminodecanoic acid). Trichormamide B (2) is a cyclic dodecapeptide characterized by the presence of four nonstandard α-amino acid residues (homoserine, N-methylisoleucine, and two 3-hydroxyleucines) and one β-amino acid residue (β-aminodecanoic acid). Trichormamide B (2) was cytotoxic against MDA-MB-435 and HT-29 cancer cell lines with IC50 values of 0.8 and 1.5 μM, respectively.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Key 2D NMR correlations of trichormamide A (1) and trichormamide B (2).
Figure 2
Figure 2
ESIMS/MS fragmentation of trichormamide A (1).
Figure 3
Figure 3
ESIMS/MS fragmentation of trichormamide B (2).

Similar articles

Cited by

References

    1. Raaijmakers J. M.; de Bruijn I.; Nybroe O.; Ongena M. FEMS Microbiol. Rev. 2010, 34, 1037–1062. - PubMed
    1. Wrasidlo W.; Mielgo A.; Torres V. A.; Barbero S.; Stoletov K.; Suyama T. L.; Klemke R. L.; Gerwick W. H.; Carson D. A.; Stupack D. G. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 2313–2318. - PMC - PubMed
    1. Vilhena C.; Bettencourt A. Mini-Rev. Med. Chem. 2012, 12, 202–209. - PubMed
    1. Cameotra S. S.; Makkar R. S. Curr. Opin. Microbiol. 2004, 7, 262–266. - PubMed
    1. Bidwai A. P.; Takemoto J. Y. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 6755–6759. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources